240 related articles for article (PubMed ID: 28293091)
1.
Yan Y; Chen YN; Zhao Q; Chen C; Lin CJ; Jin Y; Pan S; Wu JS
World J Gastroenterol; 2017 Feb; 23(8):1443-1449. PubMed ID: 28293091
[TBL] [Abstract][Full Text] [Related]
2. Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis.
Chen LW; Chang LC; Hua CC; Hsieh BJ; Chen SW; Chien RN
BMC Gastroenterol; 2017 Jan; 17(1):1. PubMed ID: 28049442
[TBL] [Abstract][Full Text] [Related]
3.
Chen QF; Zhou XD; Fang DH; Zhang EG; Lin CJ; Feng XZ; Wang N; Wu JS; Wang D; Lin WH
World J Gastroenterol; 2020 Oct; 26(37):5682-5692. PubMed ID: 33088161
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.
Voutilainen M; Färkkilä M; Mecklin JP; Juhola M; Sipponen P
Am J Gastroenterol; 1999 Nov; 94(11):3175-80. PubMed ID: 10566710
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of biopsies for Helicobacter pylori in the presence of intestinal metaplasia of the stomach.
Galiatsatos P; Wyse J; Szilagyi A
Turk J Gastroenterol; 2014 Feb; 25(1):19-23. PubMed ID: 24918125
[TBL] [Abstract][Full Text] [Related]
6. Correlation between Helicobacter pylori-associated gastric diseases and colorectal neoplasia.
Qing Y; Wang M; Lin YM; Wu D; Zhu JY; Gao L; Liu YY; Yin TF
World J Gastroenterol; 2016 May; 22(18):4576-84. PubMed ID: 27182167
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori is a risk factor for colonic neoplasms.
Sonnenberg A; Genta RM
Am J Gastroenterol; 2013 Feb; 108(2):208-15. PubMed ID: 23208272
[TBL] [Abstract][Full Text] [Related]
8. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
9. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
11. The association between Helicobacter pylori gastritis and lymphoid aggregates, lymphoid follicles and intestinal metaplasia in gastric mucosa of children.
Kara N; Urganci N; Kalyoncu D; Yilmaz B
J Paediatr Child Health; 2014 Aug; 50(8):605-9. PubMed ID: 24925694
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection.
Oksanen A; Sipponen P; Karttunen R; Rautelin H
Gut; 2003 Feb; 52(2):194-8. PubMed ID: 12524399
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori in patients with intestinal metaplasia and in controls: a serological and biopsy study in four UK centres. UK Sub-Group of the ECP-EURONUT-Intestinal Metaplasia Study Group.
Eur J Cancer Prev; 1995 Apr; 4(2):175-80. PubMed ID: 7767244
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study.
Matsuhisa T; Miki M; Yamada N; Sharma SK; Shrestha BM
Kathmandu Univ Med J (KUMJ); 2007; 5(3):295-301. PubMed ID: 18604043
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].
Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z
Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675
[TBL] [Abstract][Full Text] [Related]
17. Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia.
Wu MS; Shun CT; Lee WC; Chen CJ; Wang HP; Lee WJ; Lin JT
Br J Cancer; 1998 Jul; 78(1):125-8. PubMed ID: 9662262
[TBL] [Abstract][Full Text] [Related]
18. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
20. Type III intestinal metaplasia, Helicobacter pylori infection and gastric carcinoma risk index in an Italian series of 1750 patients.
Suriani R; Venturini I; Taraglio S; Mazzucco D; Grosso S; Predebon S; Mamo C; Tremosini S; Ballesini P; Borghi A; Zeneroli ML
Hepatogastroenterology; 2005; 52(61):285-8. PubMed ID: 15783051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
